Literature DB >> 15163557

Counteracting effects of NADPH oxidase and the Na+/Ca2+ exchanger on membrane repolarisation and store-operated uptake of Ca2+ by chemoattractant-activated human neutrophils.

Gregory R Tintinger1, Ronald Anderson.   

Abstract

This study was designed to investigate the possible involvement of NADPH oxidase and the Na(+)/Ca(2+) exchanger in regulating membrane repolarisation and store-operated uptake of Ca(2+) by FMLP (1 microM)-activated human neutrophils. Diphenyleneiodonium chloride (DPI, 5-10 microM) and KB-R7943 (2.5-10 microM), inhibitors of NADPH oxidase and the reverse mode of the Na(+)/Ca(2+) exchanger respectively, were used as pharmacological probes. Transmembrane fluxes of Ca(2+), K(+) and Na(+) were determined radiometrically, while alterations in membrane potential and cytosolic Ca(2+) were evaluated using spectrofluorimetric procedures. DPI, added to the cells at the time of maximum FMLP-activated membrane depolarisation, accelerated the rates of both membrane repolarisation and influx of Ca(2+), while KB-R7943 effectively antagonised these processes. SKF 96365 (10 microM), an antagonist of store-operated Ca(2+) channels, abolished the influx of Ca(2+) into FMLP-activated neutrophils, but had no effects on membrane repolarisation, suggesting that the Na(+)/Ca(2+) exchanger is primarily involved in mediating membrane repolarisation, thereby facilitating uptake of Ca(2+) via store-operated channels. These observations are compatible with prominent negative and positive regulatory roles for NADPH oxidase and the Na(+)/Ca(2+) exchanger respectively in regulating the rates of membrane repolarisation and store-operated uptake of Ca(2+) by chemoattractant-activated neutrophils.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163557     DOI: 10.1016/j.bcp.2004.02.029

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

Review 1.  Taming the neutrophil: calcium clearance and influx mechanisms as novel targets for pharmacological control.

Authors:  G Tintinger; H C Steel; R Anderson
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

Review 2.  Pharmacological approaches to regulate neutrophil activity.

Authors:  G R Tintinger; R Anderson; C Feldman
Journal:  Semin Immunopathol       Date:  2013-03-15       Impact factor: 9.623

3.  Protein kinase C promotes restoration of calcium homeostasis to platelet activating factor-stimulated human neutrophils by inhibition of phospholipase C.

Authors:  Gregory R Tintinger; Annette J Theron; Helen C Steel; Riana Cockeran; Lynette Pretorius; Ronald Anderson
Journal:  J Inflamm (Lond)       Date:  2009-10-30       Impact factor: 4.981

4.  Hydrogen peroxide activates calcium influx in human neutrophils.

Authors:  Miriam S Giambelluca; Oscar A Gende
Journal:  Mol Cell Biochem       Date:  2007-11-16       Impact factor: 3.396

5.  Inhibitors of TRP channels reveal stimulus-dependent differential activation of Ca2+ influx pathways in human neutrophil granulocytes.

Authors:  Elena Pantaler; Andreas Lückhoff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-06       Impact factor: 3.000

6.  Pharmacological control of neutrophil-mediated inflammation: strategies targeting calcium handling by activated polymorphonuclear leukocytes.

Authors:  Gregory R Tintinger; Helen C Steel; Annette J Theron; Ronald Anderson
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

Review 7.  Regulation of superoxide production in neutrophils: role of calcium influx.

Authors:  Sabrina Bréchard; Eric J Tschirhart
Journal:  J Leukoc Biol       Date:  2008-06-10       Impact factor: 4.962

8.  Role of the Intracellular Sodium Homeostasis in Chemotaxis of Activated Murine Neutrophils.

Authors:  Karolina Najder; Micol Rugi; Mégane Lebel; Julia Schröder; Leonie Oster; Sandra Schimmelpfennig; Sarah Sargin; Zoltán Pethő; Etmar Bulk; Albrecht Schwab
Journal:  Front Immunol       Date:  2020-09-08       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.